CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- PositionOperating margin is -14.6%, lower than 95% of its Specialty Retail peers (median 4.7%)
- FinancialsAltman Z-Score 0.95: distress zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.30BCNY491.84M · vs all stocks (USD)
Revenue (TTM)
2.76BCNY411.30M · vs all stocks (USD)
Profit Margin
-11.36%vs Specialty Retail peers
Beta
0.2390xvs all stocks
52-Week Change
-37.51%vs all stocks
Market Capitalization
3.30BCNY491.84M · vs all stocks (USD)
Enterprise Value
4.66BCNY695.10M · vs all stocks (USD)
Forward P/E
15.00xvs Specialty Retail peers
Price to Sales (TTM)
1.20xvs Specialty Retail peers
Price to Book (MRQ)
2.54xvs Specialty Retail peers
Enterprise to Revenue
1.69xvs Specialty Retail peers
Enterprise to EBITDA
-34.80xvs Specialty Retail peers
Gross Margin
28.05%vs Specialty Retail peers
Profit Margin
-11.36%vs Specialty Retail peers
Operating Margin
-14.65%vs Specialty Retail peers
Return on Assets (TTM)
-3.80%vs Specialty Retail peers
Return on Equity (TTM)
-21.90%vs Specialty Retail peers
Revenue (TTM)
2.76BCNY411.30M · vs all stocks (USD)
Revenue per Share (TTM)
7.41CNYUpdated Sep 19, 2026Quarterly Revenue Growth
5.10%vs Specialty Retail peers
Gross Profit (TTM)
751.71MCNY112.13M · vs all stocks (USD)
EBITDA (TTM)
101.24MCNY15.10M · vs all stocks (USD)
Net Income (TTM)
-313.18MCNY-46.71M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
5.10%vs Specialty Retail peers
Operating Cash Flow (TTM)
60.75MCNY9.06M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-12.51MCNY-1.87M · vs all stocks (USD)
Payout Ratio
0.00%vs Specialty Retail peers
Minority Interest (Equity)
-2.69MCNYFY2025 · Dec 31, 2025Revenue
2.68BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.88BCNYFY2025 · Dec 31, 2025Gross Profit
796.31MCNYFY2025 · Dec 31, 2025Operating Income
-123.95MCNY-18.49M · vs all stocks (USD)
Pre-tax Income
-200.55MCNYFY2025 · Dec 31, 2025Income Tax Expense
22.59MCNYFY2025 · Dec 31, 2025Net Income
-223.14MCNYFY2025 · Dec 31, 2025EBIT
-134.26MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
101.24MCNYFY2025 · Dec 31, 2025Research & Development
160.66MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
355.68MCNYFY2025 · Dec 31, 2025Other Operating Expenses
40.40MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.99MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
66.30MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.6400CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.6400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
339.01MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
339.01MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-223.14MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
6.17MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-25.60MCNYFY2025 · Dec 31, 2025Free Cash Flow
-84.99MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
309.07MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-223.14MCNYFY2025 · Dec 31, 2025Other Non-cash Items
87.23MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
147.08MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-36.76MCNYFY2025 · Dec 31, 2025Capital Expenditures
-59.39MCNYFY2025 · Dec 31, 2025Purchase of Investments
-9.83MCNYFY2025 · Dec 31, 2025Sale of Investments
2.60MCNYFY2025 · Dec 31, 2025Other Investing Activity
4.60MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-62.03MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.76BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.76BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-64.13MCNYFY2025 · Dec 31, 2025Other Financing Charges
-22.89MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-86.30MCNYFY2025 · Dec 31, 2025Shares Outstanding
340.64MSharesUpdated Sep 19, 2026Float Shares
137.25MSharesUpdated Sep 19, 2026% Held by Insiders
60.39%vs all stocks
% Held by Institutions
0.04%vs all stocks
Total Cash (MRQ)
387.23MCNY57.76M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.14CNYUpdated Sep 19, 2026Total Debt (MRQ)
1.77BCNY263.46M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.35xvs Specialty Retail peers
Current Ratio (MRQ)
0.7660xvs Specialty Retail peers
Book Value per Share (MRQ)
3.85CNYUpdated Sep 19, 2026Total Assets
4.58BCNY683.09M · vs all stocks (USD)
Total Current Assets
1.91BCNYFY2025 · Dec 31, 2025Total Liabilities
3.19BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.67BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
715.01MCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.47BCNYFY2025 · Dec 31, 2025Cash
307.55MCNYFY2025 · Dec 31, 2025Cash Equivalents
78.66MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
386.21MCNYFY2025 · Dec 31, 2025Other Short-term Investments
194.98KCNYFY2025 · Dec 31, 2025Accounts Receivable
565.54MCNYFY2025 · Dec 31, 2025Inventory
767.15MCNYFY2025 · Dec 31, 2025Accounts Payable
821.44MCNYFY2025 · Dec 31, 2025Short-term Debt
1.26BCNYFY2025 · Dec 31, 2025Other Current Liabilities
62.70MCNYFY2025 · Dec 31, 2025Long-term Debt
426.82MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
9.40MCNYFY2025 · Dec 31, 2025Common Stock (Book)
340.64MCNYFY2025 · Dec 31, 2025Retained Earnings
-30.70MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.39BCNY207.81M · vs all stocks (USD)
52-Week Low
7.67CNYUpdated Sep 19, 202652-Week High
15.55CNYUpdated Sep 19, 202652-Week Change
-37.51%vs all stocks
Beta
0.2390xvs all stocks
50-Day MA
9.55CNYUpdated Sep 19, 2026200-Day MA
10.88CNYUpdated Sep 19, 2026Avg 10-Day Volume
37.44MSharesUpdated Sep 19, 2026Avg 30-Day Volume
15.46MSharesUpdated Sep 19, 2026Diluted EPS (TTM)
-0.9200CNYUpdated Sep 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -14.6%, lower than 95% of its Specialty Retail peers (median 4.7%)Significant
Operating margin: -0.15Industry median: 0.05Industry P5: -0.06Peers compared: 73.00
Profit margin is -11.4%, lower than 95% of its Specialty Retail peers (median 2.4%)Significant
Profit margin: -0.11Industry median: 0.02Industry P5: -0.09Peers compared: 73.00
Financial Health
Altman Z-Score 0.95: distress zoneCritical
Altman Z-Score: 0.95
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Kappa Create Co., Ltd.
Tier 1ProductionUnit ReplicationRuleFlow
Shanghai Nar Industrial Co., Ltd.
Tier 1ProductionUnit ReplicationFlowSenseMaking
Quad Graphics Inc.
Tier 1ProductionUnit ReplicationFlowAttention
Hangzhou Tianyuan Pet Products Co., Ltd.
Tier 1ProductionUnit ReplicationFlowInterface
Krispy Kreme, Inc.
Tier 1ProductionUnit ReplicationFlowInterface
Tongqinglou Catering Co., Ltd.
Tier 1ProductionUnit ReplicationAttentionInterface
Liaoning Shenhua Holdings Co., Ltd.
Tier 1ProductionUnit ReplicationFlowSenseMaking
Ob Telecom Electronics Co. Ltd.
Tier 1ProductionUnit ReplicationRuleFlow
Shenzhen Special Economic Zone Real Estate & Properties Co. Ltd.
Tier 1ProductionUnit ReplicationRiskFlow
Green Tea Group Limited
Tier 1ProductionUnit ReplicationRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Veritone, Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Viking Therapeutics Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Vuzix Corporation
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated